Literature DB >> 33090973

Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.

Yuanyuan Tian1,2, Lijun Meng2,3, Ying Wang2,4, Bohan Li3, Hongshuang Yu2, Yan Zhou5, Tien Bui2, Ciril Abraham2, Alicia Li2, Yongping Zhang3, Jian Wang3, Chenchen Zhao6, Shin Mineishi6, Stefania Gallucci4, David Porter7, Elizabeth Hexner7, Hong Zheng6, Yanyun Zhang1, Shaoyan Hu3, Yi Zhang2,4.   

Abstract

Graft-versus-host disease (GVHD) causes failed reconstitution of donor plasmacytoid dendritic cells (pDCs) that are critical for immune protection and tolerance. We used both murine and human systems to uncover the mechanisms whereby GVHD induces donor pDC defects. GVHD depleted Flt3-expressing donor multipotent progenitors (MPPs) that sustained pDCs, leading to impaired generation of pDCs. MPP loss was associated with decreased amounts of MPP-producing hematopoietic stem cells (HSCs) and oxidative stress-induced death of proliferating MPPs. Additionally, alloreactive T cells produced GM-CSF to inhibit MPP expression of Tcf4, the transcription factor essential for pDC development, subverting MPP production of pDCs. GM-CSF did not affect the maturation of pDC precursors. Notably, enhanced recovery of donor pDCs upon adoptive transfer early after allogeneic HSC transplantation repressed GVHD and restored the de novo generation of donor pDCs in recipient mice. pDCs suppressed the proliferation and expansion of activated autologous T cells via a type I IFN signaling-dependent mechanism. They also produced PD-L1 and LILRB4 to inhibit T cell production of IFN-γ. We thus demonstrate that GVHD impairs the reconstitution of tolerogenic donor pDCs by depleting DC progenitors rather than by preventing pDC maturation. MPPs are an important target to effectively bolster pDC reconstitution for controlling GVHD.

Entities:  

Keywords:  Antigen presenting cells; Bone marrow transplantation; Transplantation

Year:  2021        PMID: 33090973      PMCID: PMC7773406          DOI: 10.1172/JCI136774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.

Authors:  Mojibade Hassan; Alina Ulezko Antonova; Jian Ming Li; Sakura Hosoba; Manali Rupji; Jeanne Kowalski; Adam J Perricone; David L Jaye; Henry Marsh; Michael Yellin; Steven Devine; Edmund K Waller
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-29       Impact factor: 5.742

Review 2.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

Review 3.  Role of Interferon-gamma in GVHD and GVL.

Authors:  Yong-Guang Yang; Hui Wang; Wannee Asavaroengchai; Bimalangshu R Dey
Journal:  Cell Mol Immunol       Date:  2005-10       Impact factor: 11.530

4.  Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation.

Authors:  Katie A Matatall; Mira Jeong; Siyi Chen; Deqiang Sun; Fengju Chen; Qianxing Mo; Marek Kimmel; Katherine Y King
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

5.  Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT.

Authors:  Michaël Chopin; Aaron T Lun; Yifan Zhan; Jaring Schreuder; Hannah Coughlan; Angela D'Amico; Lisa A Mielke; Francisca F Almeida; Andrew J Kueh; Ross A Dickins; Gabrielle T Belz; Shalin H Naik; Andrew M Lew; Phillipe Bouillet; Marco J Herold; Gordon K Smyth; Lynn M Corcoran; Stephen L Nutt
Journal:  Immunity       Date:  2019-01-02       Impact factor: 31.745

Review 6.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

7.  Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

Authors:  Kazuhiro Mochizuki; Lijun Meng; Izumi Mochizuki; Qing Tong; Shan He; Yongnian Liu; Janaki Purushe; Henry Fung; M Raza Zaidi; Yanyun Zhang; Ran Reshef; Bruce R Blazar; Hideo Yagita; Shin Mineishi; Yi Zhang
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

8.  Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.

Authors:  Curdin Conrad; Josh Gregorio; Yi-Hong Wang; Tomoki Ito; Stephan Meller; Shino Hanabuchi; Sonya Anderson; Neely Atkinson; Pedro T Ramirez; Yong-Jun Liu; Ralph Freedman; Michel Gilliet
Journal:  Cancer Res       Date:  2012-07-31       Impact factor: 12.701

Review 9.  Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance.

Authors:  Hongshuang Yu; Yuanyuan Tian; Ying Wang; Shin Mineishi; Yi Zhang
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 10.  Production of type I interferons: plasmacytoid dendritic cells and beyond.

Authors:  Carine Asselin-Paturel; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

View more
  10 in total

Review 1.  The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations.

Authors:  Chenchen Zhao; Yi Zhang; Hong Zheng
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

Review 2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

Authors:  Kirsten M Williams; Yoshihiro Inamoto; Annie Im; Betty Hamilton; John Koreth; Mukta Arora; Iskra Pusic; Jacqueline W Mays; Paul A Carpenter; Leo Luznik; Pavan Reddy; Jerome Ritz; Hildegard Greinix; Sophie Paczesny; Bruce R Blazar; Joseph Pidala; Corey Cutler; Daniel Wolff; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Paul J Martin; Gerard Socie; Stefanie Sarantopoulos
Journal:  Transplant Cell Ther       Date:  2021-03-02

Review 3.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

4.  Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy.

Authors:  Mar Naranjo-Gomez; Marine Cahen; Jennifer Lambour; Myriam Boyer-Clavel; Mireia Pelegrin
Journal:  Vaccines (Basel)       Date:  2021-02-08

5.  Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation.

Authors:  Ayumi Mitsune; Mitsuhiro Yamada; Naoya Fujino; Tadahisa Numakura; Tomohiro Ichikawa; Ayumi Suzuki; Shuichiro Matsumoto; Yoshiya Mitsuhashi; Koji Itakura; Tomonori Makiguchi; Akira Koarai; Tsutomu Tamada; Shota Endo; Toshiyuki Takai; Yoshinori Okada; Satoshi Suzuki; Masakazu Ichinose; Hisatoshi Sugiura
Journal:  Respir Res       Date:  2021-08-23

Review 6.  Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Authors:  Qingxiao Song; Ubaydah Nasri; Defu Zeng
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

7.  Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control.

Authors:  Jemma Nicholls; Benjamin Cao; Laetitia Le Texier; Laura Yan Xiong; Christopher R Hunter; Genesis Llanes; Ethan G Aguliar; Wayne A Schroder; Simon Phipps; Jason P Lynch; Huimin Cao; Shen Y Heazlewood; Brenda Williams; Andrew D Clouston; Christian M Nefzger; Jose M Polo; Susan K Nilsson; Bruce R Blazar; Kelli P A MacDonald
Journal:  Front Cell Dev Biol       Date:  2021-09-22

Review 8.  Murine Models Provide New Insights Into Pathogenesis of Chronic Graft-Versus-Host Disease in Humans.

Authors:  Qingxiao Song; Xiaohui Kong; Paul J Martin; Defu Zeng
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

Review 9.  LILRB4, an immune checkpoint on myeloid cells.

Authors:  Ting Yang; Yixin Qian; Xiaoting Liang; Jianbo Wu; Ming Zou; Mi Deng
Journal:  Blood Sci       Date:  2022-05-17

10.  Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors.

Authors:  Jie Lu; Kun Sun; Huiping Yang; Dan Fan; He Huang; Yi Hong; Shuiyan Wu; HuiTing Zhou; Fang Fang; YanHong Li; Lijun Meng; Jie Huang; Zhenjiang Bai
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.